catalog number : 
MBS711802
products full name : 
Rabbit anti-human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) polyclonal Antibody
products short name : 
cyclin-dependent kinase inhibitor 2A
products name syn : 
cyclin-dependent kinase inhibitor 2A (melanoma; p16; inhibits CDK4); CDKN2A; ARF; CDK4I; CDKN2; CMM2; INK4; INK4a; MLM; MTS1; TP16; p14; p14ARF; p16; p16INK4; p16INK4a; p19ARF; CDKN2A
other names : 
cyclin-dependent kinase inhibitor 2A, partial; Cyclin-dependent kinase inhibitor 2A; cyclin-dependent kinase inhibitor 2A; CDKN2A; CDK4 inhibitor p16-INK4; multiple tumor suppressor 1; cell cycle negative regulator beta; cyclin-dependent kinase 4 inhibitor A; cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4); cyclin-dependent kinase inhibitor 2A; Cyclin-dependent kinase inhibitor 2A
other gene names : 
CDKN2A; CDKN2A; ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A
uniprot entry name : 
Q5ZEY9_HUMAN
reactivity : 
Human, Mouse, Rat
purity : 
Antigen Affinity Purified
tested application : 
ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
other info1 : 
Immunogen: Human P16
other info2 : 
Storage Buffer: PBS with 0.1% Sodium Azide, 50% Glycerol, pH 7.3. -20 degree C, Avoid freeze / thaw cycles.
ncbi acc num : 
CAH59950.1
ncbi mol weight : 
6,676 Da
ncbi pathways : 
Apoptosis Pathway  198797!!Apoptosis Modulation And Signaling Pathway  198822!!Bladder Cancer Pathway  83115!!Bladder Cancer Pathway  527!!Cell Cycle Pathway  530733!!Cell Cycle, Mitotic Pathway  105765!!Cell Cycle Pathway  198811!!Cell Cycle Pathway  83054!!Cell Cycle Pathway  463!!Cellular Senescence Pathway  905991
ncbi summary : 
This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]